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Summary
Background: Integrin receptors, composed of trans-
membranea and b subunits, are essential for the develop-
ment and functioning of multicellular animals. Agonist
stimulation leads cells to regulate integrin affinity (‘‘activa-
tion’’), thus controlling cell adhesion and migration, con-
trolling extracellular-matrix assembly, and contributing
to angiogenesis, tumor cell metastasis, inflammation,
the immune response, and hemostasis. A final step in in-
tegrin activation is the binding of talin, a cytoskeletal pro-
tein, to integrinbcytoplasmicdomains.Manydifferentsig-
naling molecules that regulate integrin affinity have been
described, but a pathway that connects agonist stimula-
tion to talin binding and activation has not been mapped.
Results: We used forward, reverse, and synthetic
genetics to engineer and order an integrin activation
pathway in cells expressing a prototype activatable in-
tegrin, platelet aIIbb3. Phorbol myristate acetate (PMA)
activated aIIbb3 only after the increased expression of
both recombinant protein kinase Ca (PKCa) and talin
to levels approximating those in platelets. Inhibition
of Rap1 GTPase reduced aIIbb3 activation, whereas
activated Rap1A(G12V) bypassed the requirement for
PKC, establishing that Rap1 is downstream of PKC.
Talin binding to integrins mediates Rap1-induced acti-
vation because Rap1A(G12V) failed to activate aIIbb3
in cells expressing integrin binding-defective talin
(W359A). Rap1 activated integrins by forming an integ-
rin-associated complex containing talin in combination
with the Rap effector, RIAM. Furthermore, siRNA-medi-
ated knockdown of RIAM blocked integrin activation.
Conclusions :We have, for the first time, ordered a path-
way from agonist stimulation to integrin activation and
established the Rap1-induced formation of an ‘‘integrin
activation complex,’’ containing RIAM and talin, that
binds to and activates the integrin.
*Correspondence: mhginsberg@ucsd.edu
4 Deceased.Introduction
Agonist stimulation increases affinity (‘‘activation’’) of
cellular integrins, a process central to physiological
events such as cell migration, assembly of the extracel-
lular matrix, the immune response, and hemostasis [1,
2]. Integrins are composed of type I transmembrane
a and b subunits, each with a large extracellular domain,
a single transmembrane domain, and a cytoplasmic
domain (tail). The increase in ligand binding affinity is
usually ascribable to changes in the conformation of
the integrin extracellular domain [3], the details of which
remain a subject of lively debate. Mutational and molec-
ular modeling studies suggest that rearrangements of
the integrin a and b transmembrane domains result in
the conformational change that occurs in the extracellu-
lar domain and is responsible for activation [4–7]. Talin
binds to most integrin bcytoplasmic domains via a struc-
turally conserved PTB-like interaction, and the binding of
the talin PTB-like domain to the integrin b tail initiates in-
tegrin activation [8], presumably by causing the trans-
membrane-domain rearrangement. The broad biological
significance of this process has resulted in a vast litera-
ture implicating different signaling pathways in integrin
activation; however, there has not been acomprehensive
dissection of the signaling elements that connect agonist
receptors to the critical final step, talin binding.
The earliest studies of integrin activation concerned the
platelet integrin aIIbb3 (GPIIb-IIIa). Many of the principles
of function established with this integrin have proved
widely applicable across the entire integrin family. In
particular, the role of talin, the conserved membrane-
proximal domains, and specific structural motifs in the
cytoplasmic domains in integrin activation are similar for
most integrins [2]. Platelet agonists stimulate increased
affinity of integrin aIIbb3 for soluble ligands coincident
with talin redistribution to the plasma membrane [9]; how-
ever, agonists fail to activate recombinant aIIbb3 ex-
pressed in chinese hamster ovary (CHO) cells or several
other nucleated cells [10]. This puzzling observation has
hindered the molecular dissection of the signaling path-
ways that regulate integrinactivation. In thepresentstudy,
we have used a synthetic approach to reconstruct an in-
tegrinactivationpathway inCHO cells. Wehavethencom-
bined this approach with forward and reverse genetics to
dissect a pathway to integrin activation. We show that
Rap1-induced formation of an integrin activation complex
containing the Rap1 effector, RIAM, and talin leads to the
unmasking of the integrin binding site in talin—a final
common step in integrin activation.
Results and Discussion
Reconstitution of Agonist-Induced Activation
of Integrin aIIbb3 in a Nucleated Cell
Platelet agonists stimulate increased affinity of integrin
aIIbb3 for soluble ligands; however, agonists fail to
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1797Figure 1. Reconstitution of Agonist-Induced Activation of Integrin aIIbb3 in a Nucleated Cell
(A) Talin and PKCa expression levels in platelets, CHO cells, and CHO cells transfected with talin were assessed by western blotting and com-
pared relative to the levels of the housekeeping enzyme glyceraldehyde-3-phosphate dehydrogenase (GAPDH).
(B) CHO cells stably expressing integrin aIIbb3 (A5) were transfected with plasmids encoding HA-tagged full-length talin1 (wild-type or W359A)
either alone or in combination with PKCa. Twenty four hours after transfection, cells were treated with 100 nM PMA for 15 min, and the binding of
the activation-specific antibody, PAC-1, was assessed by flow cytometry. Depicted is the percent increase in the activation index (AI) in response
to the agonist, PMA (mean 6 standard error [SE]; nR 3).
(C) Expression of each transfected protein was assessed by western blotting.
(D) A5 cells expressing GFP-talin and PKCa were maintained in suspension and stimulated for 10 min with 100 nM PMA (left panel) or DMSO
carrier control (right panel). Cells were fixed, and localization of talin-GFP in whole-cell volume was imaged with 0.2 mm section intervals. As
shown are the z projected images of representative cells from each treatment condition.activate recombinant aIIbb3 expressed in CHO cells or
other nucleated cells [11]. Because talin binding is a final
step in integrin activation and platelets express abun-
dant talin relative to most nucleated cells [8] (Figure 1A),
we suspected that increasing talin would enable CHO
cells to activate aIIbb3 in response to a platelet agonist,
such as phorbol myristate acetate (PMA). Transfection
of aIIbb3-expressing CHO cells (A5 cells) with cDNA en-
coding talin increased talin abundance to match that in
platelets; however, this increased talin expression did
not lead to PMA-stimulated binding of PAC-1, an activa-
tion-specific aIIbb3 antibody (Figures 1A and 1B). Pro-
tein kinase Ca (PKC) is highly expressed in platelets, is
a major target of PMA, and has been implicated as a
key downstream mediator in the activation of aIIbb3 by
many platelet agonists [12]. A5 cells expressed PKCa
at less than 12% of its abundance in platelets (Figure 1A);
cotransfection of PKCa with talin resulted in abundant
expression of PKCa and PMA-stimulated PAC-1 bind-
ing. This effect also required high levels of talin expres-
sion because transfection with PKCa alone did notreconstitute aIIbb3 activation (Figures 1B and 1C).
Moreover, reconstituted integrin activation required
talin-integrin interaction because it did not occur when
a talin mutant (W359A), which fails to bind to the b3
cytoplasmic tail [13], was expressed instead of wild-
type talin (Figures 1B and 1C). Furthermore, PMA in-
duced talin redistribution to the plasma membrane in
these doubly transfected cells (Figure 1D). Thus, in-
creasing the abundance of talin and PKCa to levels
found in platelets enabled CHO cells to manifest
agonist-induced talin redistribution and activation of
integrin aIIbb3.
Rap1 GTPase Is Downstream of PKC in Integrin
aIIbb3 Activation
Talin is a known substrate for PKC [14, 15]. Recently, by
use of a combination of immobilized metal-affinity chro-
matography and mass spectrometry, we mapped the
phosphorylation sites in platelet talin 1 [16] (http://
www.cellmigration.org/resource/discovery/proteomics/
talin_total.shtml). To test the potential role of talin
Current Biology
1798phosphorylation by PKC, we mutated all of the sites
phosphorylated by PKCa in vitro (T144, T150, T430,
and S446) [16] to alanines and examined the effect of
these mutations on PKC-dependent integrin activation.
None of these mutations affected PMA-stimulated
aIIbb3 activation (Figure S1A in the Supplemental Data
available online). Thus, none of these talin phosphoryla-
tion sites are indispensable for integrin activation in this
system.
Because talin phosphorylation by PKC did not appear
to account for PKC-mediated integrin activation, we
sought alternative explanations. Recent work from Shi-
mizu’s group found that PKC can activate and localize
Rap1A GTPase by phosphorylating protein kinase D
[17]. Rap1 is implicated in activation of b1, b2, and b3
integrins [18–21], leading us to examine its relationship
to PKC in the integrin activation pathway. Rap1GAP
(Rap GTPase-activating protein) expression, which spe-
cifically blocks Rap1-mediated signaling by converting
active Rap1-GTP to inactive Rap1-GDP, almost com-
pletely inhibited PMA-induced aIIbb3 activation (Fig-
ure 2A). Furthermore, expression of a dominant-active
mutant of Rap1A [Rap1A (G12V)] could activate aIIbb3
in talin-transfected A5 cells in the absence of both
PMA and transfected PKCa. A pharmacological inhibitor
of PKC had no effect on Rap1-induced activation, in-
dicating that PKC is not downstream of Rap1 in this
pathway; however, this inhibitor efficiently blocked
PMA-induced activation of aIIbb3 (Figure 2A). Thus,
Rap1 activity is downstream of PKC and is required for
PMA-induced integrin activation.
Rap1-Mediated Integrin Activation Requires Talin
Previous work implicated both talin and Rap1 in integrin
activation [8, 22]; however, their relationship to each
other has remained uncertain. Expression of domi-
nant-active Rap1A(G12V) led to activation of aIIbb3
only in cells that had been cotransfected with talin (Fig-
ure 2B). In contrast, Rap1A(G12V) failed to activate
aIIbb3 in cells that had been transfected with the integrin
binding-defective mutant, talin(W359A), indicating that
talin binding to the integrin was required for Rap1-in-
duced aIIbb3 activation. Rap1A(G12V) did not stimulate
talin phosphorylation (Figure S1B), nor did it increase
cleavage between the talin head and rod domains (Fig-
ure 2B), two mechanisms hypothesized to induce talin
binding and activation of integrins [23, 24]. Furthermore,
mutations of multiple phosphorylation sites in talin or of
the calpain cleavage site also failed to block Rap1-
induced activation (Figure 2C, Figure S1C). Thus Rap1-
mediated integrin activation requires talin binding to
integrin b tails, suggesting that Rap1 is upstream of talin;
however, activated Rap1 did not cause integrin activa-
tion by inducing talin cleavage or phosphorylation.
Rap1 induces integrin clustering in addition to confor-
mational changes; either could lead to increased ligand
binding affinity. We used the monovalent PAC-1 Fab
fragment, which binds specifically to the active confor-
mation of aIIbb3 and is insensitive to clustering [25], to
learn whether Rap1A was modulating integrin con-
formation. Coexpression of talin and Rap1 (G12V) en-
hanced PAC-1 Fab binding to aIIbb3 (Figure S2). Thus,
Rap1 induces talin-dependent integrin activation, atleast in part, through a conformational change in the
integrin.
The foregoing analysis showed that Rap1-mediated
integrin activation requires talin when talin is overex-
pressed; however, it did not address the potential roles
of endogenous Rap1 or talin in the context of integrin ac-
tivation. When a chimera containing the cytoplasmic do-
main of a6A and b1A joined to the extracellular and
transmembrane domains of aIIbb3 is expressed in
CHO cells (abPy cells), it spontaneously binds PAC-1
in an energy-dependent manner [11]. PAC-1 binding to
abPy cells was reduced by transfection of Rap1GAP, es-
tablishing that activation depended on Rap activity
(Figure S3A). With chemical mutagenesis and selection,
abPy variants have been identified that express the chi-
meric integrin, but lack the capacity to activate it [26].
One of these mutant cell lines (J1.1) was markedly defi-
cient in talin expression (Figure 3A), and reconstitution
of talin in this cell line rescued the activation defect
(Figure 3B). Talin mutants (W359A and A360E), which
exhibit reduced binding to the b3 [13] and b1A (Fig-
ure S3B) integrin tails, were ineffective in reconstituting
PAC-1 binding, showing that reconstitution depended
on talin binding to the integrin b tail (Figure S3C). abPy
cells also express endogenous integrin a5b1 that binds
to the cell binding domain of fibronectin [3FN (9–11)].
The J1.1 cells failed to bind 3FN (9–11) (Figure 3C),
even though they expressed abundant a5b1. Binding
was reconstituted by talin transfection (Figure 3C), con-
firming that talin is also required for activation of endog-
enous b1 integrins in these cells. Transfection of J1.1
cells with Rap1A(G12V) failed to reconstitute activation,
indicating that talin is indeed required for Rap1-medi-
ated activation (Figure 3D). Moreover, two Rap1 effector
proteins, RapL (NORE1B) [27] and RIAM [28], alone or in
combination with active Rap1A(G12V), failed to stimu-
late PAC-1 binding to talin-deficient cells, whereas talin
alone rescued the activation defect (Figure 3D). Thus,
talin is required for activation of b1 integrins, and these
results now establish that the capacity of Rap1 and
its effectors to activate b1 and b3 integrins is talin
dependent.
Rap1 GTPase Activates Integrins by Regulating
the Talin-Integrin Interaction
The requirement of talin for Rap1-mediated integrin ac-
tivation suggests that talin is a downstream target of ac-
tivated Rap1. The talin F3 domain contains the principal
integrin binding site responsible for activation [13, 29];
this site is completely available in the isolated talin
head domain and its F23 fragment, but is masked in
full-length talin [24]. In cells transfected with full-length
talin, activated Rap1A(G12V) stimulated and Rap1GAP
inhibited PAC-1 binding (Figure 4A). In sharp contrast,
when these cells were transfected with talin F23, the
increased PAC-1 binding was not blocked by cotrans-
fection of Rap1GAP or enhanced by cotransfection of
Rap1A (G12V) (Figure 4A). To further confirm that the ta-
lin F23 fragment could bypass the requirement for Rap1
activity, we tested abPy cells stably expressing a consti-
tutively active integrin. In these cells, Rap1GAP reduced
PAC-1 binding (w65%), and this reduction was reversed
by coexpressed F23, but not by full-length talin (Fig-
ure S3A). Thus, talin is required for Rap1-mediated
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1799Figure 2. Rap1 GTPase Mediates PMA-Induced Integrin aIIbb3 Activation
(A) A5 cells were transfected with indicated cDNAs in combination with HA-tagged full-length talin as indicated. Twenty-four hours after trans-
fection, cells were treated with either PMA (100 nM) or the PKC inhibitor, Bisindolylmaleimide (1 mM) and PAC-1 binding was assessed by flow
cytometry (mean 6 SE; nR 3). Western blotting was used to verify protein expression.
(B) Rap1-mediated integrin activation requires talin binding to integrin b cytoplasmic domain. A5 cells were transfected with talin (wild-type or
W359A integrin binding-defective mutant) or with or without active Rap1A(G12V). After 24 hr, PAC-1 binding was measured by flow cytometry
(mean 6 SE; nR 3). Protein expression was verified by western blotting.
(C) Rap1-induced integrin activation is not mediated by calpain-dependent talin cleavage. PAC-1 binding to A5 cells transfected with either wild-
type or calpain-resistant mutant GFP-talin (L432G) [36] in combination with Rap1A(G12V) and PAC-1 binding was assessed by flow cytometry,
and protein expression was verified by western blotting.activation, and an ‘‘activated’’ fragment of talin can by-
pass the need for Rap activity; talin is therefore down-
stream of Rap1 in this pathway.
Beckerle and coworkers found that stimuli that acti-
vate integrin aIIbb3 lead to the redistribution of talin
from the platelet cytosol to the plasma membrane [9],
and we have now established that talin is a downstream
target of Rap1 in integrin activation. Therefore, we askedwhether activated Rap1 could induce a similar redistri-
bution of talin to the plasma membrane. By subcellular
fractionation, we found that expression of active
Rap1A(G12V) increased the membrane localization of
talin (Figure 4B), without changing the expression level
of talin (data not shown). Immunoblotting for integrin
aIIbb3 and RhoGDI established the authenticity of the
isolated membrane and cytosolic fractions, respectively
Current Biology
1800Figure 3. Endogenous Talin Is Required for
Integrin Activation by Rap1
(A) Activation of integrins requires endoge-
nous talin. Lysates from abPY, J1.1 (activa-
tion-defective cellular mutant derived from
abPY by chemical mutagenesis), and J1.1
cells reconstituted with talin were assayed
for talin expression by western blotting. Pax-
illin and Rap1 GTPase were also assayed for
a loading control (left panel).
(B) Integrin activation was assessed by mea-
suring PAC-1 binding by flow cytometry.
(C) Talin is required for activation of endoge-
nous a5b1 in J1.1 cells. Activation level of en-
dogenous a5b1 integrin in abPY cells, J1.1
cells, or J1.1 cells reconstituted with full-length
mouse talin was assessed by measuring the
binding of biotinylated 9–11 fragment of fibro-
nectin [FN (9–11)] via flow cytometry as de-
scribed in the Experimental Procedures (upper
panel).Solid linesdepictbindingof biotinylated
3FN (9–11) detected by streptavidin-R-phyco-
erythrin conjugate. One micromolar Ro44-
9883 was added to prevent any 3FN (9–11)
binding to aIIbb3. Filled histograms are the
binding in the presence of 10 mM ethylene di-
amine tetra-acetic acid (EDTA). Lower panels
are the flow-cytometric analysis of hamster
a5 expression. Binding of mAb for hamster a5
integrins (PB-1) was detected with a FITC-con-
jugated goat anti-mouse IgG (open histograms
with solid line). Filled histograms are the bind-
ing of mouse IgG.
(D) Active Rap1 or Rap1 in combination with
RapL or RIAM does not induce integrin activa-
tion in talin-deficient cells. Talin-deficient CHO
cells stably expressing chimeric integrins
(aIIba6b3b1) (J1.1) were transfected with vari-
ous cDNAs as indicated. Cells were then har-
vested and analyzed for PAC-1 binding by
flow cytometry as described above. Expres-
sion of proteins was verified by western blot-
ting [HA antibody for talin and Rap1A(G12V)
and myc antibody for RIAM and RapL].(Figure 4B, right panel). We confirmed this result by ex-
amining the localization of talin in cells transfected with
GFP-talin. Cotransfection of talin with Rap1A(G12V) led
to relocalization of talin to the plasma membrane within
clusters that colocalized with aIIbb3 (Figure 4C). The
Rap1-induced association of talin with integrin aIIbb3
was also observed in coimmunoprecipitation experi-
ments. Cells were transfected with GFP-talin with or
without active Rap1A(G12V) or Rap1GAP; a 3-fold in-
crease in GFP-talin-associated aIIbb3 was seen in cells
that had been cotransfected with Rap1A (G12V) but not
with Rap1GAP (Figure 4D, left panel) or with talin alone.
Rap1GAP had reduced the slight activation observed in
talin-transfected cells (Figure 4A), but did not reduce the
small amount of talin coprecipitating with aIIbb3 in the
absence of Rap1A(G12V) (Figure 4D). Thus, Rap1 stimu-
lates the membrane localization and integrin association
of talin.
RIAM Mediates the Formation of a Rap1-Induced
Integrin Activation Complex
To see whether the Rap1 effectors RapL/NORE1B or
RIAM couple Rap1 to talin, we expressed these proteins
in talin-transfected cells. RIAM enhanced talin-mediatedintegrin activation, even in the absence of Rap1A(G12V)
(Figure 5A), and dramatically increased Rap1-induced
activation (Figure 5A). In sharp contrast, RapL/NORE1B,
alone or in combination with active Rap1A, did not affect
the activation of aIIbb3 (Figure 5A). RIAM is required
for Rap1-induced aIIbb3 activation, because shRNA-
mediated knockdown of RIAM reduced Rap1A-induced
talin-dependent integrin activation (Figure 5B). The
specificity of this result was confirmed by the failure of
control shRNA to block activation (Figure 5B) and by re-
constitution with a RIAM construct that contained seven
base mismatches with the shRNA (Figure S4). To exam-
ine the mechanism of RIAM-mediated activation, we
assessed the association of RIAM with talin. RIAM
coimmunoprecipitated with talin and aIIbb3, and the
association was strongly stimulated by cotransfection
of Rap1A(G12V) (Figure 5C). Furthermore, RIAM was co-
localized with clustered, membrane-associated talin in
Rap1A(G12V)-transfected cells (Figure 5D). Thus, RIAM
mediates the formation of a Rap1-induced integrin acti-
vation complex, containing talin and RIAM, that binds
to and activates the integrin.
The foregoing experiments showed that constitutively
activated Rap1A(G12V) could drive the association of
Reconstructing Integrin Activation
1801Figure 4. Rap1 GTPase Activates Integrin aIIbb3 by Stimulating the Interaction of Talin with Integrin aIIbb3
(A) A5 cells were transfected with cDNAs encoding the F23 fragment of talin (amino acids 206–405) or full-length talin in combination with active
Rap1 [Rap1A(G12V)] or Rap1GAP. PAC-1 binding was measured by flow cytometry, and protein expression was verified by western blotting.
(B) Expression of active Rap1 [Rap1A(G12V)] enhances membrane localization of talin. A5 cells were transfected with HA-tagged full-length talin
alone or in combination with Rap1A(G12V). Membrane and cytosolic fractions were separated, and the distribution of HA-talin was assessed by
western blotting. Integrin aIIbb3 and RhoGDI were used as markers for the membrane and cytosolic fractions, respectively.
(C) Epifluorescent images of A5 cells expressing GFP-talin (top panels) or GFP-talin and Rap1A(G12V) (bottom panels) stained to show aIIbb3
integrin (red) and GFP-talin (green) localization. Images are z projections of the entire cell volume. The scale bar represents 10 mm. The integrin
and GFP-talin coclusters in Rap1A(G12V)-transfected cells (bottom panels) are located on the nonadherent portion of the cell membrane.
(D) Active Rap1 GTPase enhances talin association with integrin aIIbb3. A5 cells transfected with either GFP-talin alone or along with
Rap1A(G12V) or Rap1GAP were lysed, integrins were immunoprecipitated with anti-b3 antibody (Rb8053), and associated GFP-talin was de-
tected by western blotting (left panel). Expression of each protein in cell lysates was assessed by western blotting [GFP antibody for talin,
PMI-1 for integrin aIIb, and HA antibody for Rap1A(G12V) and Rap1GAP] (right panel). Densitometry was used for quantitative comparison
(AlphaImager 2000, Alpha Innotech).
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1802Figure 5. RIAM Mediates Rap1 GTPase-Induced Talin-Dependent Integrin Activation
(A) RIAM but not RapL enhances Rap1A(G12V)-induced integrin activation. A5 cells were transfected with full-length talin in combination with
either RapL or RIAM in the presence or absence of active Rap1A(G12V) as indicated. PAC-1 binding was measured by flow cytometry 24 hr after
transfection (mean 6 SE; nR 3).
(B) RIAM knockdown abrogates Rap1A(G12V)-induced talin-dependent integrin activation. A5 cells were transfected with plasmids encoding
shRNA (control shRNA or RIAM knockdown, 2AM) in combination with the indicated cDNAs. After 48 hr, cells were harvested and analyzed
for PAC-1 binding by flow cytometry (left panel), and protein expression was verified by western blotting. Densitometry was used to quantify
RIAM knockdown (right panel).
(C) Expression of active Rap1 GTPase increases RIAM association with talin. A5 cells transfected with GFP-talin alone, GFP-talin and RIAM, or
GFP-talin and RIAM in combination with Rap1A(G12V) were lysed as described in the Experimental Procedures. Myc-tagged RIAM was immu-
noprecipitated with myc antibody, and associated GFP-talin was detected by western blotting (left panel). Expression of each protein in cell
lysates (WCL) was detected by western blotting [GFP antibody for talin, RIAM antibody for RIAM, and HA antibody for Rap1A(G12V)] (right panel).
(D) Epifluorescent images of CHO-A5 cells expressing talin-GFP and RIAM-Myc, without (top panels) or with Rap1A(G12V) (bottom panels),
stained with anti-myc to reveal RIAM(red) and talin-GFP (green) localization. Images are z projections of the entire cell volume. The scale
bar represents 10 mm. RIAM and talin coclusters in Rap1A(G12V)-transfected cells (bottom panels) are located on the nonadherent plasma
membrane.
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1803Figure 6. Association of RIAM and Talin in Spreading CHO Cells, Fibroblasts, and Stimulated Platelets
(A) Association of RIAM and talin during aIIbb3-mediated cell spreading on fibrinogen. CHO-A5 cells expressing recombinant talin-GFP and
RIAM-Myc were permitted to adhere to fibrinogen-coated coverslips for 2 hr and were stained with anti-myc to reveal RIAM (red) and talin-
GFP (green) localization and were observed by epifluorescence microscopy. The scale bar represents 10 mm. Yellow arrows and arrowheads
indicate talin and RIAM colocalized in focal adhesion or lamellipodia, respectively. Green arrowheads indicate fibrillar adhesion containing talin,
but lacking RIAM.
(B) Association of endogenous talin and RIAM staining in fibroblasts. NIH 3T3 fibroblasts were permitted to attach to fibronectin-coated cover-
slips for 15 min and were then double stained for talin and RIAM. The scale bar represents 10 mm. Note colocalization of staining in focal com-
plexes and in some focal adhesions, but lack of RIAM staining in more mature fibrillar adhesions and larger focal adhesions.
(C) Association of RIAM antigen and talin in stimulated platelets. A suspension of washed human platelets was incubated at 37C for 1 min in the
presence (TRAP) or absence (middle column) of 200 mM thrombin receptor agonist peptide. After solubilization in 1% NP40, the resulting lysates
were immunoprecipitated with anti-talin (8d4) or irrelevant IgG, the resulting precipitates were resolved by SDS-PAGE, and western blots were
probed with polyclonal anti-RIAM or anti-talin.RIAM with talin. We wished to assess the interaction of
these two proteins in response to physiological stimuli.
We first examined the potential colocalization of these
talin and RIAM in response to cell adhesion to the extra-
cellular matrix. When A5 cells were cotransfected with
talin and RIAM and permitted to adhere to fibrinogen,
they initially extended lamellipodia, leading to spread-
ing, and then formed typical talin-containing focal adhe-
sions. During the initial spreading, there was complete
colocalization of talin with RIAM in the lamellipodia,
a site known to contain activated integrins [30, 31] (Fig-
ure 6A). Some of the talin-containing focal adhesionsinitially contained RIAM (Figure 6A) but at later times
(>2 hr after attachment), the mature focal and fibrillar ad-
hesions were devoid of RIAM (Figure 6A and data not
shown). To examine these interactions when all proteins
were present at natural abundance, we visualized the lo-
calization of endogenous talin and RIAM immunostain-
ing in murine fibroblasts attaching to fibronectin. As in
the transfected CHO cells, immunofluorescent staining
for RIAM and talin extensively localized in lamellipodia
and early focal adhesions, whereas mature focal adhe-
sions frequently lacked RIAM (Figure 6B and data
not shown). Finally, we exploited the observation that
Current Biology
1804Figure 7. Connecting Agonist Stimulation to
Integrin Activation
Depicted are core connections between ago-
nists and integrins. Agonist receptors (e.g., G
protein-coupled receptors, tyrosine-kinase-
coupled receptors [37, 38]) induce the forma-
tion of diacylglycerol (DAG) and increased
Ca2+ leading to the activation and/or trans-
location of active GTP bound Rap1 to the
plasma membrane via activation of protein
kinase C (PKC) [17] or a Rap guanine nucleo-
tide exchanger (Rap-GEF) [39]. At the plasma
membrane, activated Rap interacts with
RIAM [28], leading to the recruitment of talin
to form the integrin activation complex, thus
unmasking the integrin binding site in talin
F3 leading to integrin activation.Rap1B is abundant in human platelets and is activated in
response to stimulation of the thrombin receptor [32].
When the human thrombin receptor was stimulated
with thrombin receptor agonist peptide (TRAP) [33],
containing the sequence SFFLRN, and immunoprecipi-
tated with a talin antibody, RIAM immunoblots revealed
a talin-associated protein in the stimulated but not the
resting platelets (Figure 6C). Thus, in both platelets
and fibroblasts, talin associates with RIAM coincident
with b3 and b1 integrin activation.
Integrin activation controls cell adhesion, migration,
and extracellular-matrix assembly, thus contributing to
angiogenesis, tumor-cell metastasis, inflammation, the
immune response, and hemostasis [1, 3]. Talin binding
to integrin b cytoplasmic domains is a final step in integ-
rin activation [8]. Here, we described a synthetic
strategy to reconstruct the signaling pathway between
PMA and the activation of integrin aIIbb3 and used this
strategy to map connections between an agonist and in-
tegrin activation (Figure 7). Certain key components of
this pathway appear to be widely used in many cellular
contexts and with many integrins: These components
are talin [8], Rap1 [22], and RIAM [28], or their paralogs.
These proteins participate in the formation of an integrin
activation complex that enables the unmasking of the in-
tegrin activating function of talin; this function does not
require proteolytic cleavage or phosphorylation of talin.
As shown here, variations in cellular abundance of the
components of the integrin activation complex or in their
regulators, such as PKCa, can then account for the cell-
type specificity of integrin activation. Indeed, it is now
possible to use this core pathway (Figure 7) as a tem-
plate to integrate and rationalize a hitherto fragmented
literature connecting different agonists and signaling
pathways that control integrin activation. This newfound
ability to synthetically reconstruct these pathways in
heterologous cells will enable a quantitative and muta-
tional analysis of the contributions of each component
of the pathway and provides a ready means to discover
and analyze new modulators of integrin activation.
Experimental Procedures
Flow Cytometry
PAC1 binding was measured by two-color flow cytometry as previ-
ously described [11]. In brief, 24 hr after transfection, cells were
harvested and were incubated first with 0.1% PAC1 ascites in the
presence of the competitive inhibitor Ro43-5054 at 1 mM or anti-LIBS6 ascites and then with R-phycoerythrin-conjugated goat
anti-mouse IgM antibody on ice. PAC1 bindings were then mea-
sured with a FACScan (Becton Dickinson, Mountain View, California)
flow cytometer, and the collected data were analyzed with CellQuest
software (Becton Dickinson). To obtain numerical estimates of
integrin activation, we calculated an activation index (AI), defined
as 100 3 (Fo 2 Fr)/(FoLIBS6 2 Fr), where Fo is the median fluores-
cence intensity (MFI) of PAC1 binding, Fr is the MFI of PAC1 binding
in the presence of competitive inhibitor (Ro43-5054, 1 mM), and
FoLIBS6 is the MFI of PAC1 binding in the presence of 2 mM
anti-LIBS6.
PAC-1 Fab binding to cells was assessed by a similar flow-
cytometric method as previously described [25, 34]. For maximum
integrin activation, cells were incubated with 1 mM MnCl2.
FN (9–11) binding to endogenous integrin a5b1 was assayed by
two-color flow cytometry as described above for PAC-1 binding.
Biotinylated FN (9–11) staining in the presence of 5 mM EDTA was
used to estimate nonspecific binding. In addition, 1 mM Ro44-9883
(Hoffmann-LaRoche, Basel, Switzerland) was added to the cells
during the incubation with biotinylated FN (9–11) to eliminate any
FN (9–11) binding to integrin aIIbb3.
Subcellular Fractionation
CHO cells were transfected with cDNAs encoding HA-talin or HA-
talin plus HA-Rap1A (G12V). Twenty-four hours after transfection,
these cells were subjected to the subcellular fractionation as
described previously [35]. Detailed procedures are described in
the Supplemental Data.
Platelet Preparation
Platelets were isolated from fresh ACD-anticoagulated human blood
and washed as previously described [16] with the addition of 10 mM
E64, a calpain inhibitor, to each of the wash and final suspension
buffers.
Coimmunoprecipitation and Western Blotting
Coimmunoprecipitations and western-blotting procedures are de-
scribed in the Supplemental Data.
Clustering of Talin-GFP in Suspension Cells
A5 (aIIbb3-expressing CHO cells) cells transfected with PKCa and
talin-GFP were serum-starved and maintained in suspension in
1%BSA/DMEM for 3.5 hr. Cells were then treated with dimethyl sulf-
oxide (DMSO) or with 100 nM PMA for 10 min and fixed in suspension
with 3.7% formaldehyde. After washes with PBS, cells were
mounted on coverslips with SlowFade antifade reagent (Molecular
Probes S-7461) and examined as described below.
Coclustering of aIIbb3 Integrin or RIAM-Myc with Talin-GFP
CHO-A5 cells transfected with talin-GFP, or with talin-GFP and
RIAM-Myc, with or without RapV12, were adhered on fibrinogen-
coated coverslips for 2 hr in complete Dulbecco’s modified Eagle’s
medium (DMEM). To label aIIbb3 integrins, 40 mg/ml D57 monoclonal
antibody were incubated with the cells for 20 min prior to fixation
with 3.7% formaldehyde in PBS. For staining of RIAM-Myc, cells
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1805were fixed with 3.7% formaldehyde, permeabilized in 0.1% Triton
X-100 for 5 min, blocked with 1%BSA/PBS for 1 hr, and incubated
with 1:100 dilution c-Myc monoclonal antibody (Clontech) in
1%BSA/1% normal goat serum/PBS overnight at 4C. Subse-
quently, the coverslips were incubated with TRITC-conjugated
goat anti-mouse secondary antibody (Santa Cruz) for 1 hr in
1%BSA/PBS, washed, and slide-mounted in Prolong Gold antifade
reagent (Molecular Probes) for imaging as described below.
Epi-Fluorescent Imaging
Adherent cells were imaged with a 603 oil immersion objective on a
Nikon Eclipse TE2000-U microscope. Suspension-fixed cells were
imaged at 0.2 um section intervals with a 603 oil immersion objec-
tive on a Nikon Eclipse TE2000-U microscope controlled by Slide-
Book imaging software. Images were subsequently deconvoluted
with a nearest-neighbor algorithm and shown as a maximal projec-
tion of Z sections (as in Figure 1D) or volume rendered with Image J.
Adhered cells were imaged at 0.1 or 0.2 um section intervals with
a 403 oil immersion objective. Images as shown are maximal projec-
tions of Z sections with Image J (http://rsb.info.nih.gov/ij/).
Supplemental Data
Supplemental Data include Experimental Procedures and four fig-
ures and are available with this article online at: http://www.
current-biology.com/cgi/content/full/16/18/1796/DC1/.
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